Transition Therapeutics Announces Initiation of a Phase I Clinical Study of TT-301 - MarketWatch (press release)

Transition Therapeutics Announces Initiation of a Phase I Clinical Study of TT-301 MarketWatch (press release) TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage ("ICH") and ... and more »

Arthritis Patient Successfully Treated With Fat Stem Cells Tells His Story - MarketWatch (press release)

Arthritis Patient Successfully Treated With Fat Stem Cells Tells His Story MarketWatch (press release) Medistem collaborator Dr. Jorge Paz Rodriquez was invited to give a talk at Del Mar College in Texas by arthritis patient Dusty Durrill. ... and more »

New Clues to Herniated Disc Pain - BusinessWeek

New Clues to Herniated Disc Pain BusinessWeek "It's a product of a specific subgroup of immune cells that involved in autoimmune phenomena like rheumatoid arthritis and asthma, but not in the body's ... Immune System Could Be A Cause Of Back PainKDKA all 7 news articles »

Surprising find may yield new avenue of treatment for painful herniated discs - PhysOrg.com

Surprising find may yield new avenue of treatment for painful herniated discs PhysOrg.com Doing so could reduce the painful inflammation associated with degenerative disc disease, and halt the evolution of arthritis. It may also reduce the need ... and more »